Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – FDA (biotech/pharma) External News
Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform - TradingView
Google News – Oncology External News
Medicus Pharma shifts focus to cancer drug CD22... - Pluang
Google News – Pharmaceuticals External News
Mirum Pharmaceuticals, Inc. Announces Management Changes - marketscreener.com
Google News – Pharmaceuticals External News
Ionis Pharmaceuticals gets $85 price target des... - Pluang
Google News – Pharmaceuticals External News
Gregg Gorniak on Turning DSCSA Compliance Investment Into Shared Value - Pharmaceutical Commerce
Google News – Pharmaceuticals External News
Butler Tech program helps build workforce for hundreds of new pharmaceutical jobs - WKRC
Google News – Clinical Trials External News
Pharmalittle: We're reading about another Novartis trial failure, a Novo Nordisk setback, and more - STAT
Google News – Pharmaceuticals External News
REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT - GlobeNewswire
Google News – Clinical Trials External News
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 at Upcoming Medical Meetings - Investing News Network
Google News – Biopharma External News
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business - PR Newswire
Google News – Biopharma External News
Aspire Biopharma changes name to Aspire-Lakewood Holdings - Investing.com
Google News – Biopharma External News
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - ACCESS Newswire
Google News – Pharmaceuticals External News
NRx Pharmaceuticals to Present at Three September Investor Conferences - citybiz
Google News – Pharmaceuticals External News